• 1
  • 2
  • 3

Invited Speaker

Tsung-Hsien Lee

Director, Institute of Medicine, Chung-Shan Medical University

Professor, Institute of Medicine and Department of Obstetrics and Gynecology, Chung-Shan Medical University
 

Bio: I graduated from Taipei Medical College (now Taipei Medical University) with a degree of medical doctor in 1995. In July 1997, I entered the National Taiwan University Hospital, Taipei, Taiwan as a resident physician in the Department of Obstetrics and Gynecology, and after four years of residency training, I was admitted to Taiwan Association of Obstetrics and Gynecology as a specialist in 2001. In the same year, I entered the Division of Reproductive Endocrinology and Infertility, Department of Obstetrics and Gynecology, National Taiwan University Hospital as a trainee physician, receiving two years of subspecialty training in infertility, and during the period of chief resident and two years of training physician, I studied at the Institute of Clinical Medicine, National Taiwan University College of Medicine, and obtained a master's degree in medicine in 2003 The master's thesis focused on the new IVF treatment at that time, and discussed the related phenomena and applications of the gonadotropin antagonist protocol for IVF patients.
In July 2003, I served as an attending physician in the Department of Obstetrics and Gynecology of National Taiwan University Hospital and entered the doctoral program of the Institute of Clinical Medicine, National Taiwan University College of Medicine, where I focused on the correlation with reactive nitrogen species (such as nitric oxide) and antioxidants (such as glutathione) during embryonic development during IVF treatment. In 2005, I was qualified as a lecturer by the Ministry of Education and taught trainee physician in the Department of Obstetrics and Gynecology of the College of Medicine of National Taiwan University.
From April 2007 to the Chung Shan Medical University Hospital, he served as an attending physician in the Department of Obstetrics and Gynecology, and in August 2008, he was qualified as an assistant professor by the Ministry of Education, and at the same time worked at the National Taiwan University College of Medicine. In August 2009, I transferred to the Institute of Medicine, Chung Shan Medical University as a full-time assistant professor, and since then, in addition to medical students, I has also been required to teach master's students and help graduate students learn clinical research methods. After receiving his Ph.D. in Clinical Medicine from National Taiwan University College of Medicine in 2012, he taught more students from the Institute of Medicine of Chung Shan Medical University to doctoral students. During this period, my research areas included not only the effects of oxidative stress on sperm and embryos in reproductive medicine, but also in the field of stem cells. In February 2021, he obtained the qualification of professor appointed by the Ministry of Education, and the number of medical students, master's students, and doctoral students under my guidance gradually increased, and my research fields also expanded from obstetrics and gynecology and reproductive medicine to medical research such as cancer, urology, and big data. I have published more than 100 SCI papers so far.
Since 2010, I have served as the director of the Center of Reproductive Medicine in the Department of Obstetrics and Gynecology of Chung Shan Medical University Hospital, presided over the Reproductive Medicine Laboratory, and is responsible for managing the relevant personnel of the Center of Reproductive Medicine and the affairs related to IVF treatment. Since 2015, I have been elected as a supervisor of the Taiwan Society for Reproductive Medicine for five consecutive terms, and at the same time also served as a supervisor and director of the Taiwan Association of Obstetrics and Gynecology, and engaged in the public affairs of reproductive medicine.

Speech Title:  From Pixels to Pregnancies: The Application of AI for Reproductive Medicine

Speech Abstract: Artificial intelligence (AI) now performs specialist-level tasks in several fields of medicine, and reproductive medicine is a natural candidate. In vitro fertilization (IVF) combines repetitive decisions, marked inter-observer variability, abundant digital data and measurable outcomes. This talk introduces AI for obstetricians and gynecologists through a five-rung evidence ladder, from retrospective model development to randomized trials and real-world implementation. The aim is to help clinicians see where AI fits in the IVF workflow and how to appraise it critically. Four applications are reviewed. First, deep learning models for embryo selection showed high accuracy in retrospective studies, yet the first large randomized trial (1,066 patients, 14 clinics) did not demonstrate noninferiority to embryologists for clinical pregnancy (46.5% vs. 48.2%), although the AI selected the same embryo in most cases and worked faster. Second, non-invasive ploidy prediction reached an AUC of 0.76 internally but lower values at external clinics. Third, models for gonadotrophin dosing, trigger timing and sperm retrieval remain largely retrospective. Fourth, large language models give useful fertility counseling information but produce occasional factual errors. The talk closes with five questions clinicians should ask before adopting any AI tool, concerning training data, outcome, level of evidence, transparency and reporting standards.
 


 

 

 


 

 

 

 

 

Submission Method

Electronic Submission System ( .pdf)

Full paper Template:  (Word Template)
                                             (
LateX Template)

Abstract Template: (download here)

Contact Information

Conference Secretary: Ms. Josie SHEN

ICHSM E-mail: ichsm@cbees.net

Contact number: +86-021-59561560